Bone Marrow Transplantation

Top Story

HLA biomarker may predict GVHD risk following HSCT

August 12, 2015

The HLA-DPB1 rs9277534 expression marker influenced the risk for graft-versus-host disease associated with HLA-DPB1 mismatching, according to study results published in The New England Journal of Medicine.

Patients who undergo hematopoietic stem cell transplantation from HLA-DPB1–mismatched donors with a high expression of rs9277534 faced a greater risk for developing GVHD, the researchers reported.

Institution Notes

Vanderbilt appoints director of pediatric stem cell transplant program

August 9, 2015
Carrie Kitko, MD, has been named associate professor of pediatrics and director of the pediatric stem cell transplant program within the division of hematology/oncology…
In the Journals

Lymphoma survivors face increased risk for cardiac problems after HSCT

July 29, 2015
Left ventricular systolic dysfunction and heart failure occurred more frequently than previously reported in adult survivors of lymphoma who underwent autologous…
In the Journals

Fever present in HHV-6 reactivation after pediatric stem cell transplant

July 22, 2015
The reactivation of human herpesvirus-6 after pediatric allogenic stem cell transplantation may explain the previously unknown origin of fever in 30% of patients…
CME
Updates in Immunotherapy – Philadelphia 2015

Updates in Immunotherapy – Philadelphia 2015

This activity is supported by an educational grant from Merck & Co., Inc.

The promise of immunotherapy in oncology has become a reality with the US Food and Drug Administration (FDA) approval…
More »
Meeting News Coverage Video
4131355725001 th

CD19-targeted T-cells show potential in B-ALL, allogeneic stem cell transplantation

June 19, 2014
CHICAGO — Eunice Wang, MD, associate professor in the department of medicine at Roswell Park Cancer Institute…
More »
CME
Hematology Oncology Case Consults

The Patient with Multiple Myeloma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with multiple myeloma.
More »
In the Journals

HLA biomarker may predict GVHD risk following HSCT

August 12, 2015
The HLA-DPB1 rs9277534 expression marker influenced the risk for graft-versus-host disease associated with HLA-DPB1 mismatching, according to study…
Institution Notes

Vanderbilt appoints director of pediatric stem cell transplant program

August 9, 2015
Carrie Kitko, MD, has been named associate professor of pediatrics and director of the pediatric stem cell transplant program within the division of…
In the Journals

Lymphoma survivors face increased risk for cardiac problems after HSCT

July 29, 2015
Left ventricular systolic dysfunction and heart failure occurred more frequently than previously reported in adult survivors of lymphoma who…
In the Journals

Fever present in HHV-6 reactivation after pediatric stem cell transplant

July 22, 2015
The reactivation of human herpesvirus-6 after pediatric allogenic stem cell transplantation may explain the previously unknown origin of fever in 30%…
In the Journals

Algorithm may improve reporting of mortality after allogeneic HSCT

July 16, 2015
The review and adjudication of cause-specific deaths within 1 year after allogeneic hematopoietic stem cell transplantation has led to the…
Ran Reshef, MD In the Journals

Higher CD8 T-cell dose from younger donors improves allogeneic HSCT outcomes

July 2, 2015
A higher graft CD8 dose from younger donors — even if they are not related to the patient — predicted improved survival in patients with…
In the Journals

HSCT improves survival for older patients with multiple myeloma

June 30, 2015
Hematopoietic stem cell transplantation improved OS for elderly patients with multiple myeloma in the real-world setting, according to results of a…
In the Journals

Graft-versus-host disease causes enteric bacterial BSI in children after HCT

May 19, 2015
Acute gastrointestinal graft-versus-host disease is likely to cause greater enteric bacterial bloodstream infection density in children who have…
In the Journals

Gene therapy effectively treats complications of Wiskott-Aldrich syndrome in children

May 18, 2015
In a small cohort of children and adolescents with Wiskott-Aldrich syndrome, autologous hematopoietic stem cell gene therapy led to clinical…
Stephen D. Nimer, MD Industry News

Cancer center director receives award from Bone Marrow Foundation

May 17, 2015
Stephen D. Nimer, MD, director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, received the Dr. E…
More Headlines »
morganatic-roan
morganatic-roan